ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,207Medicare Part D Prescriptions Filled, Including Refills

Rank: 108 out of 2343

$977K Total Retail Price of All Prescriptions

Rank: 139 out of 2343

502 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 502 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 502 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 16,955 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
FUROSEMIDE 971 949 1 6
CITALOPRAM HBR 691 658 2 17
LISINOPRIL 630 605 3 3
LEVOTHYROXINE SODIUM 610 577 4 2
SIMVASTATIN 551 507 5 1
OMEPRAZOLE 487 460 6 4
DONEPEZIL HCL 458 458 7 21
RISPERIDONE 357 323 8 61
AMLODIPINE BESYLATE 336 321 9 5
METOPROLOL TARTRATE 320 306 10 7
JANTOVEN 320 306 10 81
NAMENDA 310 307 12 36
POLYETHYLENE GLYCOL 3350 252 215 13 54
MIRTAZAPINE 248 242 14 41
GABAPENTIN 246 214 15 16
METFORMIN HCL 243 214 16 9
TRAZODONE HCL 236 226 17 53
METOPROLOL SUCCINATE 213 212 18 14
WARFARIN SODIUM 213 161 18 8
DIVALPROEX SODIUM 209 185 20 105
POTASSIUM CHLORIDE 190 183 21 18
QUETIAPINE FUMARATE 188 169 22 77
TAMSULOSIN HCL 184 184 23 29
ATENOLOL 184 178 23 12
DIGOXIN 176 173 25 35
FENTANYL 174 137 S2 26 69
VENLAFAXINE HCL ER 172 172 27 87
ATORVASTATIN CALCIUM 157 147 28 10
OXYCODONE HCL 152 124 S2 29 67
IPRATROPIUM-ALBUTEROL 150 136 30 99
SERTRALINE HCL 147 142 31 20
HYDROCODONE-ACETAMINOPHEN 145 142 S3 32 13
ADVAIR DISKUS 144 144 33 34
TRAMADOL HCL 136 136 34 25
ESCITALOPRAM OXALATE 133 118 35 55
OXYCONTIN 129 121 S2 36 138
ALLOPURINOL 124 124 37 31
LANTUS 123 116 38 51
OXYCODONE-ACETAMINOPHEN 122 64 S2 39 49
CLOPIDOGREL 121 118 40 26
HYDROCHLOROTHIAZIDE 119 119 41 11
PRAVASTATIN SODIUM 118 114 42 15
PREDNISONE 117 115 43 37
FLUTICASONE PROPIONATE 116 116 44 46
EXELON 116 114 44 129
FINASTERIDE 115 115 46 80
OXYBUTYNIN CHLORIDE ER 114 114 47 149
HUMALOG 113 106 48 131
CARBIDOPA-LEVODOPA 109 109 49 85
FAMOTIDINE 105 94 50 60
GLIPIZIDE 98 88 51 56
ISOSORBIDE MONONITRATE ER 96 95 52 32
ABILIFY 95 82 53 159
CARVEDILOL 94 88 54 27
CIPROFLOXACIN HCL 93 89 55 72
SEROQUEL 87 82 56 171
CEPHALEXIN 83 76 57 111
PLAVIX 83 77 57 38
LEVOFLOXACIN 79 67 59 106
GLIPIZIDE ER 76 64 60 115
HYDRALAZINE HCL 76 71 60 92
SPIRONOLACTONE 75 75 62 65
ALENDRONATE SODIUM 73 73 63 28
NOVOLOG 72 54 64 110
NYSTATIN 68 67 65 172
CYMBALTA 68 67 65 74
DIOVAN 67 67 67 23
SANTYL 66 55 68 195
TRIAMTERENE-HCTZ 65 59 69 57
LEVETIRACETAM 65 62 69 104
PAROXETINE HCL 62 62 71 66
SPIRIVA 62 61 71 48
SUCRALFATE 61 61 73 248
NYSTATIN-TRIAMCINOLONE 59 50 74 249
OLANZAPINE 56 56 75 121
DILTIAZEM 24HR ER 56 55 75 76
AMIODARONE HCL 52 48 77 158
MELOXICAM 51 50 78 68
TRIAMCINOLONE ACETONIDE 51 50 78 137
LYRICA 51 47 78 135
ENALAPRIL MALEATE 50 50 81 58
BUSPIRONE HCL 50 50 81 146
LOPERAMIDE 50 50 81 238
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 1, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.